Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders

被引:20
作者
Bolton-Maggs, P. H. B. [1 ,2 ]
Favaloro, E. J. [3 ]
Hillarp, A. [4 ]
Jennings, I. [5 ]
Kohler, H. P. [6 ,7 ]
机构
[1] Manchester Blood Ctr, SHOT Off, Manchester M13 9LL, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Westmead Hosp, Dept Haematol, ICPMR, Westmead, NSW 2145, Australia
[4] Malmo Univ Hosp, Dept Clin Chem, Univ & Reg Labs Reg Skane, Malmo, Sweden
[5] UK NEQAS Blood Coagulat, Sheffield, S Yorkshire, England
[6] Univ Hosp Bern, Univ Clin Hematol, Lab Hemostasis Res, CH-3010 Bern, Switzerland
[7] Spital Netz Bern Hosp, Dept Internal Med, Bern, Switzerland
关键词
bleeding disorders; external quality assurance; factor XIII deficiency; laboratory diagnosis; von Willebrand disease; VON-WILLEBRAND-FACTOR; IMPROVED PERFORMANCE-CHARACTERISTICS; COLLAGEN-BINDING ASSAY; FACTOR-XIII DEFICIENCY; COAGULATION-FACTOR; WORLD FEDERATION; DISEASE; RISTOCETIN; DISCRIMINATION; MANAGEMENT;
D O I
10.1111/j.1365-2516.2012.02830.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
. von Willebrand disease (VWD) is the most common inherited bleeding disorder, but variable severity and several classification types mean that diagnosis is often not straightforward. In many countries, the assays are not readily available and/or are not well standardized. The latest methods and the basis of VWD are discussed here, together with information from the international quality assessment programme (IEQAS). Factor XIII deficiency is a rare, but important bleeding disorder, which may be missed or diagnosed late. A discussion and update on this diagnosis is considered in the final section of our review.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 42 条
  • [1] Factor XIII deficiency
    Anwar, R
    Miloszewski, KJA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) : 468 - 484
  • [2] The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
    Bolton-Maggs, PHB
    Perry, DJ
    Chalmers, EA
    Parapia, LA
    Wilde, JT
    Williams, MD
    Collins, PW
    Kitchen, S
    Dolan, G
    Mumford, AD
    [J]. HAEMOPHILIA, 2004, 10 (05) : 593 - 628
  • [3] BOLTONMAGGS PHB, 1995, THROMB HAEMOSTASIS, V73, P194
  • [4] AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN
    BROWN, JE
    BOSAK, JO
    [J]. THROMBOSIS RESEARCH, 1986, 43 (03) : 303 - 311
  • [5] von Willebrand Factor Assay Proficiency Testing The North American Specialized Coagulation Laboratory Association Experience
    Chandler, Wayne L.
    Peerschke, Ellinor I. B.
    Castellone, Donna D.
    Meijer, Piet
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (06) : 862 - 869
  • [6] Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay
    Chen, D.
    Tange, J. I.
    Meyers, B. J.
    Pruthi, R. K.
    Nichols, W. L.
    Heit, J. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 1993 - 2002
  • [7] Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay
    Favaloro, E. J.
    Mohammed, S.
    McDonald, J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (12) : 2842 - 2844
  • [8] Favaloro EJ, 2000, THROMB HAEMOSTASIS, V83, P127
  • [9] Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: A question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro, Emmanuel J.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (01) : 113 - 127
  • [10] An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult
    Favaloro, Emmanuel J.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (08) : 727 - 744